Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CV Sciences (CVSI) EBT (2016 - 2025)

CV Sciences' EBT history spans 14 years, with the latest figure at $378000.0 for Q4 2025.

  • On a quarterly basis, EBT fell 73.02% to $378000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$367000.0, a 40.61% decrease, with the full-year FY2025 number at -$367000.0, down 40.61% from a year prior.
  • EBT hit $378000.0 in Q4 2025 for CV Sciences, up from -$382000.0 in the prior quarter.
  • Over the last five years, EBT for CVSI hit a ceiling of $5.7 million in Q1 2023 and a floor of -$9.0 million in Q4 2021.
  • Historically, EBT has averaged -$1.0 million across 5 years, with a median of -$603000.0 in 2024.
  • Biggest five-year swings in EBT: tumbled 2477.5% in 2022 and later surged 476.63% in 2023.
  • Tracing CVSI's EBT over 5 years: stood at -$9.0 million in 2021, then skyrocketed by 73.62% to -$2.4 million in 2022, then surged by 63.59% to -$860000.0 in 2023, then soared by 262.91% to $1.4 million in 2024, then plummeted by 73.02% to $378000.0 in 2025.
  • Business Quant data shows EBT for CVSI at $378000.0 in Q4 2025, -$382000.0 in Q3 2025, and -$261000.0 in Q2 2025.